#50 Can Lineage Cell Therapeutics Proprietary Cell-Based Therapy Platform Change Treatment Development?
Update: 2022-05-27
Description
Have you ever thought about having replacement parts for your body? It sounds like science fiction, but it’s now as real as the eyes you’re using to read this, thanks to cell-based therapy. Brian Culley is one of the leaders in this field. He is the CEO of Lineage Cell Therapeutics, a company developing treatments for multiple indications based on their proprietary cell-based therapy platform. Leveraging in-house manufacturing, they are attacking multiple indications from ophthalmology to immuno-oncology. In this episode, Brian joins Ammon Rivera to explain what their strategy is, where they are currently in the development process, and where they’re going from there.
Support the showCheck me out on LinkedIn https://www.linkedin.com/in/ammonr/
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
